Joanne Bryce Gemini Therapeutics, Inc. (GMTX) insider trading activity

GMTX Quotes by TradingView

Joanne Bryce is Chief Financial Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 23,665 shares of GMTX, which is worth approximately $576,716. The most recent transaction as insider was on Jan 10, 2024, when has been sold 18,165 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.7K
0% 3M change
846.6% 12M change
Total Value Held $576,716

Joanne Bryce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2024
BUY
Grant, award, or other acquisition
-
18,165 Added 43.43%
23,665 Common Stock
Dec 27 2023
BUY
Exercise of conversion of derivative security
$29,580 $9.86 p/Share
3,000 Added 35.29%
5,500 Common Stock
Dec 12 2023
SELL
Open market or private sale
$163,050 $65.22 p/Share
2,500 Reduced 50.0%
2,500 Common Stock
Dec 12 2023
BUY
Exercise of conversion of derivative security
$6,625 $2.65 p/Share
2,500 Added 33.33%
5,000 Common Stock
Dec 05 2023
SELL
Open market or private sale
$143,058 $56.3 p/Share
2,541 Reduced 50.41%
2,500 Common Stock
Dec 05 2023
BUY
Exercise of conversion of derivative security
$1,293 $1.01 p/Share
1,281 Added 20.26%
5,041 Common Stock
Sep 11 2023
BUY
Exercise of conversion of derivative security
$24,650 $9.86 p/Share
2,500 Added 39.94%
3,760 Common Stock
Sep 01 2023
SELL
Open market or private sale
$52,990 $52.99 p/Share
1,000 Reduced 44.25%
1,260 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
$2,650 $2.65 p/Share
1,000 Added 30.67%
2,260 Common Stock
Aug 01 2023
SELL
Open market or private sale
$226,366 $50.07 p/Share
4,521 Reduced 78.2%
1,260 Common Stock
Aug 01 2023
BUY
Exercise of conversion of derivative security
$4,566 $1.01 p/Share
4,521 Added 43.88%
5,781 Common Stock
Jun 28 2023
SELL
Open market or private sale
$507,024 $50.34 p/Share
10,072 Reduced 88.88%
1,260 Common Stock
Jun 28 2023
BUY
Exercise of conversion of derivative security
$7,958 $1.01 p/Share
7,880 Added 41.02%
11,332 Common Stock
JB

Joanne Bryce

Chief Financial Officer
Watertown, MA

Track Institutional and Insider Activities on GMTX

Follow Gemini Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Insider Trading

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

News

Receive news related to Gemini Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GMTX